Anemia drugs

Biotech

GSK pulls off clean sweep of endpoint hits in anemia phase 3

The studies hit their goals but, with the FDA rejecting AstraZeneca’s rival drug, doubts remain about GSK’s chances of getting to market. 
Nick Paul Taylor Nov 8, 2021 7:25am

GSK files for Japanese approval of oral anemia drug

Aug 21, 2019 8:54am

FibroGen’s renal anemia drug closer to EU filing

Sep 20, 2018 9:48am

Prolific dealmakers Akebia and Vifor pen anemia drug pact

May 16, 2017 5:42am

Akebia, Otsuka pen $865M expansion to anemia pill pact

Apr 26, 2017 4:48am

Otsuka backs Akebia with $1B deal on anemia drug vadadustat

Dec 21, 2016 2:51am